Skip to main content
. 2017 Apr 11;8:197. doi: 10.3389/fphar.2017.00197

Table 1.

Demographic and clinical characteristics of the subjects enrolled.

Patients entered/completers 28/24
Sex (M/F) 15/13
Age (years), mean ± SD 45.8 ± 11.7
Educational level (years), mean ± SD 9.6 ± 3.1
Duration of prior AP treatment (months), mean ± SD 25.6 ± 34.1
SGAs (Dose range – mg/d) n. entered/completers
Olanzapine (5–20 mg/d) 7/7
Clozapine (100–350 mg/d) 7/6
Quetiapine (50–100 mg/d) 6/5
Risperidone (3–4 mg/d) 4/3
Paliperidone (9–12 mg/d) 4/3